日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nipah virus on the radar: The choice to catch early or catch up later

尼帕病毒疫情预警:是及早发现还是亡羊补牢?

Lacey, Hester; Jain, Shivani; Reinis, Aigars; Jain, Nityanand

Quantum Random Number Generation Using Nanodiamonds and Nanopillar-Isolated Single NV Centers

利用纳米金刚石和纳米柱隔离的单个NV色心生成量子随机数

Rudzitis, Oskars; Lazda, Reinis; Krumins, Valts; Meilerts, Heinrihs; Jani, Mona; Auzinsh, Marcis

Full-Spectrum Hyperspectral Modeling of Leaf Dry Matter Content Using a Stacked Ensemble Framework

利用堆叠集成框架进行叶片干物质含量的全光谱高光谱建模

Alksnis, Reinis; Alsina, Ina; Duma, Mara; Dubova, Laila; Gross, Uldis; Harbovska, Tetiana

Immune cell infiltration correlates with intestinal permeability, inflammation, and gastrointestinal symptoms in type 1 diabetes

免疫细胞浸润与1型糖尿病患者的肠道通透性、炎症和胃肠道症状相关

Zalizko, Polina; Isaks, Reinis; Pahirko, Leonora; Fedulovs, Aleksejs; Krustins, Eduards; Nazarovs, Jurijs; Dubencovs, Sergejs; Salmenkari, Hanne; Lehto, Markku; Jēkabsons, Kaspars; Riekstiņa, Una; Groop, Per-Henrik; Sandholm, Niina; Sokolovska, Jeļizaveta

The Clinical Role of the Adenoid Microbiome in the Development of Adenoid Hypertrophy and Otitis Media with Effusion

腺样体微生物群在腺样体肥大和渗出性中耳炎发生发展中的临床作用

Sokolovs-Karijs, Oļegs; Brīvība, Monta; Gudrā, Dita; Saksis, Rihards; Zodāne, Annija Alise; Rozenberga, Maija; Bunka, Laura; Frigotto, Anna; Osīte, Jana; Reinis, Aigars; Segliņa, Gunta; Krūmiņa, Angelika

Molecular Mechanisms Underlying the Pathogenicity of Pseudomonas aeruginosa

铜绿假单胞菌致病性的分子机制

Krūmiņa, Angelika; Reinis, Aigars; Jeske, Agneta; Zeltiņa, Indra; Vīksna, Ludmila

Mechanisms of Pseudomonas aeruginosa Resilience Against Antibiotic Treatment and Outlooks of Emerging Treatment Strategies

铜绿假单胞菌对抗生素治疗的耐药机制及新兴治疗策略展望

Krūmiņa, Angelika; Zeltiņa, Indra; Simsone, Paula; Eulitz, Emile; Reinis, Aigars; Vīksna, Ludmila

Epidemiology, Virulence Factors, and Antibacterial Resistance of Klebsiella spp.: The Known Unknowns

肺炎克雷伯菌属的流行病学、毒力因子和抗菌素耐药性:已知的未知

Krūmiņa, Angelika; Zeltiņa, Indra; Vikmane, Lauma Māra; Reinis, Aigars; Vīksna, Ludmila

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Nanrilkefusp alfa (SOT101) 是一种 IL-15 受体 βγ 超激动剂,可作为单药或与抗 PD-1 药物联合用于治疗晚期癌症患者。

Stephane Champiat ,Elena Garralda ,Vladimir Galvao ,Philippe A Cassier ,Carlos Gomez-Roca ,Iphigenie Korakis ,Peter Grell ,Aung Naing ,Patricia LoRusso ,Romana Mikyskova ,Nada Podzimkova ,Milan Reinis ,Kaissa Ouali ,Andreu Schoenenberger ,Joachim Kiemle-Kallee ,Sascha Tillmanns ,Richard Sachse ,Ulrich Moebius ,Radek Spisek ,David Bechard ,Lenka Palova Jelinkova ,Irena Adkins ,Aurelien Marabelle

Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.

新型 PD-1 靶向、活性优化的 IL-15 突变体 SOT201 以顺式作用提供优于 PD1-IL2v 的抗肿瘤活性

Matuskova Hana, Marasek Pavel, Mazhara Vladyslav, Simonova Ekaterina, Kosinova Lucie, Danek Petr, Danova Klara, Sajnerova Katerina, Malatova Iva, Hrabankova Klara, Greco Denise, Martinec Ondrej, Fabisik Matej, Podzimkova Nada, Hladikova Kamila, Behalova Katerina, Antosova Zuzana, Sirova Milada, Mikyskova Romana, Reinis Milan, Kovar Marek, Béchard David, Moebius Ulrich, Palova Jelinkova Lenka, Spisek Radek, Steegmaier Martin, Adkins Irena